TNF Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
TNF Pharmaceuticals has a total shareholder equity of $382.3K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.4M and $26.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$13.07m |
| Equity | US$382.29k |
| Total liabilities | US$26.00m |
| Total assets | US$26.38m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0A8D's short term assets ($14.4M) exceed its short term liabilities ($5.8M).
Long Term Liabilities: 0A8D's short term assets ($14.4M) do not cover its long term liabilities ($20.2M).
Debt to Equity History and Analysis
Debt Level: 0A8D is debt free.
Reducing Debt: 0A8D currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0A8D has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0A8D has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 10.2% each year.